We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+10.22%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
AUM
$199M
AUM Growth
+$17.9M
Cap. Flow
+$3.47M
Cap. Flow %
1.74%
Top 10 Hldgs %
20.15%
Holding
680
New
55
Increased
231
Reduced
76
Closed
66

Sector Composition

Rank Sector Weight
1 Technology 25.49%
2 Real Estate 13.6%
3 Healthcare 10.93%
4 Industrials 10.75%
5 Consumer Staples 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPSC icon
651
SPS Commerce
SPSC
$2.69B
-56
Closed -$9K
TACT icon
652
Transact Technologies
TACT
$57.6M
-190
Closed -$3K
TAK icon
653
Takeda Pharmaceutical
TAK
$56B
-150
Closed -$2K
TLT icon
654
iShares 20+ Year Treasury Bond ETF
TLT
$40.5B
-5
Closed -$1K
UAVS icon
655
AgEagle Aerial Systems
UAVS
$59.2M
0
UBER icon
656
Uber
UBER
$159B
-22
Closed -$1K
UDR icon
657
UDR
UDR
$12.1B
-24
Closed -$1K
USMV icon
658
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
-782
Closed -$57K
VNQ icon
659
Vanguard Real Estate ETF
VNQ
$38.6B
-70
Closed -$7K
WH icon
660
Wyndham Hotels & Resorts
WH
$5.29B
-14
Closed -$1K
CNH
661
CNH Industrial
CNH
$16.9B
-179
Closed -$3K
GAP
662
The Gap Inc
GAP
$7.74B
-31
Closed -$1K
MTVA
663
MetaVia Inc
MTVA
$7.39M
0
CASA
664
DELISTED
Casa Systems, Inc. Common Stock
CASA
-210
Closed -$1K
SUNW
665
DELISTED
Sunworks, Inc.
SUNW
-188
Closed -$1K
MRTX
666
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-17
Closed -$3K
DBD
667
DELISTED
Diebold Nixdorf Incorporated
DBD
$0 ﹤0.01%
42
-200
-83% -$1.86K
BLCM
668
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$0 ﹤0.01%
58
ALR
669
DELISTED
AlerisLife Inc
ALR
-20
Closed
VIVO
670
DELISTED
Meridian Bioscience Inc
VIVO
-140
Closed -$3K
FEO
671
DELISTED
First Trust/abrdn Emerging Opportunity Fund
FEO
-250
Closed -$4K
MNDT
672
DELISTED
Mandiant, Inc. Common Stock
MNDT
-30,492
Closed -$543K
POLY
673
DELISTED
Plantronics, Inc.
POLY
-60
Closed -$2K
MIME
674
DELISTED
Mimecast Limited
MIME
-72
Closed -$5K
DRNA
675
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-126
Closed -$3K

Similar funds

Truvestments Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Truvestments Capital held 680 positions worth $199M, up 9.9% from $181M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Truvestments Capital's Q4 2021 filing shows 55 new, 231 increased, 76 reduced and 66 closed positions. Its largest new stake was VMware, Inc: 2,648 shares worth $307K. The largest sale was Mandiant, Inc. Common Stock, an estimated $543K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Real Estate and Healthcare.

  • Truvestments Capital's largest Q4 2021 buy was VMware, Inc: 2,648 shares worth $307K.
  • Truvestments Capital added most to Vanguard Morningstar Growth ETF in Q4 2021, an estimated $264K increase.
  • Truvestments Capital's biggest Q4 2021 reduction was Dell, cutting an estimated $321K.
  • Truvestments Capital fully exited Mandiant, Inc. Common Stock in Q4 2021, selling an estimated $543K.
  • Truvestments Capital's ten largest holdings make up 20% of its $199M portfolio in Q4 2021.
  • Truvestments Capital opened 55 new positions and closed 66 in Q4 2021.
  • Truvestments Capital's portfolio value rose 9.9% quarter-over-quarter to $199M.

Based on Truvestments Capital's 13F filing for Q4 2021, filed 14 Feb 2022.